Clinically meaningful improvements were seen in QoL with ETN treatment in both groups , but the change from baseline scores at week 24 were significantly higher in PsA 2 years group for joint pain ( p = 0.007 ) , arthritis activity ( p = 0.01 ) , EQ-5D utility ( p = 0.046 ) and EQ-5D VAS ( p = 0.04 ) responses .